Literature DB >> 27989223

Antibacterial Effect of Synthetic Peptide LyeTxI and LyeTxI/β-Cyclodextrin Association Compound Against Planktonic and Multispecies Biofilms of Periodontal Pathogens.

Edison Andrés Cruz Olivo1, Daniel Santos2, Maria Elena de Lima2, Vera Lúcia Dos Santos3, Rubén Dario Sinisterra4, María Esperanza Cortés5.   

Abstract

BACKGROUND: Antimicrobial peptides (AMPs) have shown rapid and potent effect against planktonic bacteria. However, control of periodontopathic biofilms is a challenge even for AMPs. Thus, the present study evaluates in vitro antimicrobial activity of synthetic peptide LyeTxI and association compound LyeTxI/β-cyclodextrin (βCD) against multispecies biofilms.
METHODS: Sensibility to LyeTxI and LyeTxI/βCD was determined for planktonic Gram-negative periodontopathogens. Time-kill kinetic assay was performed at minimum inhibitory concentrations (MICs) in all planktonic strains. Multispecies biofilms were grown on pegs using a biofilm device and studied by scanning electron microscopy at 2, 5, and 10 days. Minimal biofilm eradication concentration (MBEC) was determined for 2- and 4-day multispecies biofilms. Metabolic activity of biofilms was determined by fluorometry study.
RESULTS: Biofilms showed reproducible cell density on pegs of the biofilm device. LyeTxI and LyeTxI/βCD were active against all strains tested at concentrations ≤62.5 μg/mL. Kinetic assays showed rapid bactericidal effect of LyeTxI against all periodontopathogens. MBECs of LyeTxI and LyeTxI/βCD against multispecies 2-day biofilms were two-fold higher than MICs of cells shed from biofilms. LyeTxI was able to reduce multispecies 2-day metabolic activity by 90%. Multispecies 4-day biofilms were tolerant to all agents tested.
CONCLUSIONS: LyeTxI and LyeTxI/βCD are active against periodontopathic bacteria, showing rapid bactericidal effect and may be used to prevent biofilm development. In the future, AMPs could be therapeutic tools for treatment of periodontitis.

Entities:  

Keywords:  Antimicrobial cationic peptides; Fusobacterium; Porphyromonas; biofilms; cyclodextrins; periodontitis

Mesh:

Substances:

Year:  2016        PMID: 27989223     DOI: 10.1902/jop.2016.160438

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  5 in total

1.  LyeTxI-b, a Synthetic Peptide Derived From Lycosa erythrognatha Spider Venom, Shows Potent Antibiotic Activity in Vitro and in Vivo.

Authors:  Pablo V M Reis; Daiane Boff; Rodrigo M Verly; Marcella N Melo-Braga; María E Cortés; Daniel M Santos; Adriano M de C Pimenta; Flávio A Amaral; Jarbas M Resende; Maria E de Lima
Journal:  Front Microbiol       Date:  2018-04-06       Impact factor: 5.640

2.  Intravitreal injection of the synthetic peptide LyeTx I b, derived from a spider toxin, into the rabbit eye is safe and prevents neovascularization in a chorio-allantoic membrane model.

Authors:  Flavia Rodrigues da Silva; Mayara Rodrigues Brandão de Paiva; Lays Fernanda Nunes Dourado; Rummenigge Oliveira Silva; Carolina Nunes da Silva; Bruna Lopes da Costa; Cibele Rodrigues Toledo; Maria Elena de Lima; Armando da Silva-Cunha
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2018-11-21

3.  A New Topical Eye Drop Containing LyeTxI-b, A Synthetic Peptide Designed from A Lycosa erithrognata Venom Toxin, Was Effective to Treat Resistant Bacterial Keratitis.

Authors:  Carolina Nunes da Silva; Flavia Rodrigues da Silva; Lays Fernanda Nunes Dourado; Pablo Victor Mendes Dos Reis; Rummenigge Oliveira Silva; Bruna Lopes da Costa; Paula Santos Nunes; Flávio Almeida Amaral; Vera Lúcia Dos Santos; Maria Elena de Lima; Armando da Silva Cunha Júnior
Journal:  Toxins (Basel)       Date:  2019-04-04       Impact factor: 4.546

Review 4.  Antimicrobial Peptides as an Alternative for the Eradication of Bacterial Biofilms of Multi-Drug Resistant Bacteria.

Authors:  Janaína Teixeira Costa de Pontes; Anna Beatriz Toledo Borges; Cesar Augusto Roque-Borda; Fernando Rogério Pavan
Journal:  Pharmaceutics       Date:  2022-03-15       Impact factor: 6.321

5.  Shortened derivatives from native antimicrobial peptide LyeTx I: In vitro and in vivo biological activity assessment.

Authors:  Leonardo Lima Fuscaldi; Joaquim Teixeira de Avelar Júnior; Daniel Moreira Dos Santos; Daiane Boff; Vívian Louise Soares de Oliveira; Karla Aparecida Guimarães Gusmão Gomes; Rosana de Carvalho Cruz; Patrícia Luciana de Oliveira; Paula Prazeres Magalhães; Patricia Silva Cisalpino; Luiz de Macêdo Farias; Elaine Maria de Souza-Fagundes; Johannes Delp; Marcel Leist; Jarbas Magalhães Resende; Flávio Almeida Amaral; Adriano Monteiro de Castro Pimenta; Simone Odília Antunes Fernandes; Valbert Nascimento Cardoso; Maria Elena de Lima
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.